Tag Archives: glucose control

Finding time for a full workout can be difficult, but what if two minutes of movement still mattered? Emerging research on exercise snacking for diabetes suggests that brief bursts of activity spread throughout the day may reduce post-meal glucose excursions and limit some metabolic effects of prolonged sitting. Instead of …

When a person develops diabetes at a young age, is not overweight, and has several family members with the condition, is it really type 2 diabetes? In many cases, the answer may be no. A growing body of evidence suggests that thousands of people worldwide are living with HNF1A-MODY, a …

When most people think about diabetes, they picture the pancreas, insulin, or blood sugar. However, researchers are increasingly asking a different question: what if another organ has been quietly influencing glucose metabolism all along? Surprisingly, the answer may be the skeleton. For decades, bone was viewed primarily as the body’s …

For decades, diabetes treatment has centered on medications, insulin therapy, lifestyle changes, and increasingly sophisticated medical devices. But what if a completely different approach could help regulate blood sugar without adding another drug? That intriguing question is driving research into hepatic neuromodulation for diabetes, a promising field that uses focused …

For many people living with diabetes, gaining access to an automated insulin delivery (AID) system can be life-changing. These technologies help improve glycemic outcomes, reduce hypoglycemia risk, and ease the daily burden of diabetes management. Yet despite their proven benefits, many patients continue to face lengthy delays before gaining access. …

For decades, body mass index (BMI) has been the standard tool for assessing metabolic health and diabetes risk. However, many clinicians now question whether weight alone tells the full story. Some people with a “normal” BMI still develop insulin resistance and type 2 diabetes, while others with higher body weight …

The conversation around DIY diabetes technology and patient-led insulin automation has changed dramatically over the past few years. What once existed on the margins of diabetes care is now gaining recognition from major medical organizations and healthcare providers. In fact, the 2026 American Diabetes Association (ADA) Standards of Care continue …

Automated insulin delivery for people with type 2 diabetes is entering a new phase. What once seemed reserved for highly specialized endocrinology clinics is now moving steadily into primary care offices across the country. Following the updated 2026 American Diabetes Association Standards of Care and recent FDA clearances, more adults …

Can a therapy improve metabolic health even if the scale does not budge? This question is becoming increasingly relevant as clinicians observe patients benefiting from GLP-1 therapy even without significant weight loss. While weight reduction has long been a primary goal of incretin-based therapies, emerging data suggest that metabolic improvements …

As more patients with diabetes achieve and maintain glycemic targets, the conversation is shifting from “how can we intensify therapy?” to “when is it safe and appropriate to de‑intensify diabetes therapy?” De‑intensify diabetes therapy is becoming a high‑value clinical goal for many clinicians caring for adults with type 2 diabetes, …